All Stories

  1. Multi-Omic Candidate Screening for Markers of Severe Clinical Courses of COVID-19

    Article • Journal of Clinical Medicine, September 2023, MDPI AG

    Dr. med. Katharina Lechner

  2. De Novo Lipogenesis-Related Monounsaturated Fatty Acids in the Blood Are Associated with Cardiovascular Risk Factors in HFpEF Patients

    Article • Journal of Clinical Medicine, July 2023, MDPI AG

    Dr. med. Katharina Lechner

  3. Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, March 2023, Springer Science + Business Media

    Dr. med. Katharina Lechner

  4. Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial

    Article • Clinical Research in Cardiology, January 2023, Springer Science + Business Media

    Dr. med. Katharina Lechner

  5. Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial

    Article • October 2022, Research Square

    Dr. med. Katharina Lechner

  6. Obesity and cardiovascular disease: beyond body weight and energy balance

    Article • European Journal of Preventive Cardiology, September 2022, Oxford University Press (OUP)

    Dr. med. Katharina Lechner

  7. Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF Trial

    Article • Biomedicines, September 2022, MDPI AG

    Dr. med. Katharina Lechner

  8. Re-evaluating low-carbohydrate diets and mortality

    Article • The Lancet Public Health, July 2022, Elsevier

    Dr. med. Katharina Lechner

  9. Weight-gain Independent Effect of Mirtazapine on Fasting Plasma Lipids in Healthy Men

    Article • June 2022, Research Square

    Dr. med. Katharina Lechner

  10. Low-Carb-Diäten – die unvoreingenommene und evidenzbasierte Betrachtung ist überfällig

    Article • Aktuelle Ernährungsmedizin, February 2022, Thieme Publishing Group

    Dr. med. Katharina Lechner

  11. Erratum zu: Gesättigte Fettsäuren und kardiovaskuläres Risiko: Ist eine Revision der Ernährungsempfehlungen angezeigt?

    Article • Herz, November 2021, Springer Science + Business Media

    Dr. med. Katharina Lechner

  12. Gesättigte Fettsäuren und kardiovaskuläres Risiko

    Article • Herz, September 2021, Springer Science + Business Media

    Dr. med. Katharina Lechner

  13. Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial

    Article • Clinical Research in Cardiology, August 2021, Springer Science + Business Media

    Dr. med. Katharina Lechner

  14. TCT Connect 2020 Trial Update: FORECAST, COMBINE OCT-FFR and DEFINE-PCI

    Article • European Cardiology Review, May 2021, Medical Media Communications, Ltd. T/A Radcliffe Cardiology

    Dr. med. Katharina Lechner

  15. Waist-to-height ratio and metabolic phenotype compared to the Matsuda index for the prediction of insulin resistance

    Article • Scientific Reports, April 2021, Springer Science + Business Media

    Dr. med. Katharina Lechner

  16. Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression

    Article • Frontiers in Molecular Biosciences, March 2021, Frontiers

    Dr. med. Katharina Lechner

  17. Correction to: Impact of a 2‑year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes

    Article • Cardiovascular Diabetology, February 2021, Springer Science + Business Media

    Dr. med. Katharina Lechner

  18. Paradigmenwechsel in den Empfehlungen zur Ernährung bei Typ-2-Diabetes

    Article • Info Diabetologie, February 2021, Springer Science + Business Media

    Dr. med. Katharina Lechner

  19. Personalisierte Behandlungskonzepte bei arterieller Hypertonie

    Article • Herz, January 2021, Springer Science + Business Media

    Dr. med. Katharina Lechner

  20. Kardiovaskuläre Manifestationen von COVID-19

    Article • MMW - Fortschritte der Medizin, January 2021, Springer Science + Business Media

    Dr. med. Katharina Lechner

  21. Impact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes

    Article • Cardiovascular Diabetology, December 2020, Springer Science + Business Media

    Dr. med. Katharina Lechner

  22. Comparison of Waist-to-height Ratio, Hypertriglyceridemic Waist Phenotype, Triglycerides to HDL-C Ratio and Fasting Plasma Glucose With the Matsuda Index for the Prediction of Insulin Resistance/hyperinsulinemia

    Article • December 2020, Research Square

    Dr. med. Katharina Lechner

  23. The Effect of Exercise Intensity and Volume on Metabolic Phenotype in Patients with Metabolic Syndrome: A Randomized Controlled Trial

    Article • Metabolic Syndrome and Related Disorders, November 2020, Mary Ann Liebert Inc

    Dr. med. Katharina Lechner

  24. Inter-individual differences in the response to an exercise training intervention in patients with metabolic syndrome

    Article • European Heart Journal, November 2020, Oxford University Press (OUP)

    Dr. med. Katharina Lechner

  25. Impact of A Two-Year Trial of Nutritional Ketosis on Indices of Cardiovascular Disease Risk in Patients With Type 2 Diabetes

    Article • September 2020, Research Square

    Dr. med. Katharina Lechner

  26. Should We Use Genetic Scores in the Determination of Treatment Strategies to Control Dyslipidemias?

    Article • Current Cardiology Reports, September 2020, Springer Science + Business Media

    Dr. med. Katharina Lechner

  27. Recommendations on sodium intake for cardiovascular health: conviction or evidence?

    Article • European Heart Journal, July 2020, Oxford University Press (OUP)

    Dr. med. Katharina Lechner

  28. Your athlete-patient has a high coronary artery calcification score—‘Heart of Stone’. What should you advise? Is exercise safe?

    Article • British Journal of Sports Medicine, March 2020, BMJ

    Dr. med. Katharina Lechner

  29. How to prevent cardiovascular events from recurring

    Article • European Journal of Preventive Cardiology, March 2020, SAGE Publications

    Dr. med. Katharina Lechner

  30. High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation

    Article • Metabolic Syndrome and Related Disorders, March 2020, Mary Ann Liebert Inc

    Dr. med. Katharina Lechner

  31. Vitamin D and athletic performance: perspectives and pitfalls

    Article • German Journal of Sports Medicine, February 2020, Deutsche Zeitschrift Fur Sportmedizin

    Dr. med. Katharina Lechner

  32. The ‘heart’ of preventive cardiology: Lifestyle medicine for the treatment of cardiometabolic diseases

    Article • European Journal of Preventive Cardiology, January 2020, SAGE Publications

    Dr. med. Katharina Lechner

  33. Exercise recommendations in athletes with coronary artery calcification

    Article • European Journal of Preventive Cardiology, October 2019, SAGE Publications

    Dr. med. Katharina Lechner

  34. THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronism

    Article • European Journal of Endocrinology, October 2019, Bioscientifica

    Dr. med. Katharina Lechner

  35. Lifestyle and Atherosclerosis

    Article • European Journal of Preventive Cardiology, August 2019, SAGE Publications

    Dr. med. Katharina Lechner

  36. Demenz und metabolisch-vaskuläre Risikofaktoren: Möglichkeiten der Prävention

    Article • DMW - Deutsche Medizinische Wochenschrift, August 2019, Thieme Publishing Group

    Dr. med. Katharina Lechner

  37. Are Atherogenic Lipoprotein Phenotype and Inflammation Indicative of Plaque Phenotype and Clinical Stability in Coronary Artery Disease?

    Article • JAMA Cardiology, July 2019, American Medical Association (AMA)

    Dr. med. Katharina Lechner

  38. Poster Session 1

    Article • European Journal of Preventive Cardiology, June 2019, SAGE Publications

    Dr. med. Katharina Lechner, Professor Izabella Uchmanowicz

  39. Sind Low-Carb-Diäten lebensgefährlich?

    Article • Aktuelle Ernährungsmedizin, May 2019, Thieme Publishing Group

    Dr. med. Katharina Lechner

  40. Effect of mirtazapine on glucose metabolism and resting energy expenditure: Observations in “super-healthy” men under highly standardized conditions

    Article • February 2019, Thieme Publishing Group

    Dr. med. Katharina Lechner

  41. Effect of mirtazapine on metabolism and energy substrate partitioning in healthy men

    Article • JCI Insight, January 2019, American Society for Clinical Investigation

    Dr. med. Katharina Lechner

  42. Mediterrane Ernährung hilfreich bei kardiovaskulärer Primärprävention

    Article • DMW - Deutsche Medizinische Wochenschrift, September 2018, Thieme Publishing Group

    Dr. med. Katharina Lechner

  43. Ernährungsempfehlungen beim metabolisch-vaskulären Syndrom

    Article • Aktuelle Ernährungsmedizin, April 2018, Thieme Publishing Group

    Dr. med. Katharina Lechner

  44. A Walnut-Enriched Diet Affects Gut Microbiome in Healthy Caucasian Subjects: A Randomized, Controlled Trial

    Article • Nutrients, February 2018, MDPI AG

    Dr. med. Katharina Lechner

  45. A Walnut-Enriched Diet Reduces Lipids in Healthy Caucasian Subjects, Independent of Recommended Macronutrient Replacement and Time Point of Consumption: a Prospective, Randomized, Controlled Trial

    Article • Nutrients, October 2017, MDPI AG

    Dr. med. Katharina Lechner

  46. Ernährungsempfehlungen beim metabolisch-vaskulären Syndrom

    Article • DMW - Deutsche Medizinische Wochenschrift, October 2017, Thieme Publishing Group

    Dr. med. Katharina Lechner

  47. WALNUT-ENRICHED DIET REDUCES LIPIDS IN HEALTHY CAUCASIAN SUBJECTS, INDEPENDENT OF RECOMMENDED MACRONUTRIENT REPLACEMENT

    Article • Journal of the American College of Cardiology, March 2017, Elsevier

    Dr. med. Katharina Lechner

  48. So steuern Sie das Essverhalten Ihrer Patienten in die richtige Richtung

    Article • MMW - Fortschritte der Medizin, April 2016, Springer Science + Business Media

    Dr. med. Katharina Lechner

  49. Hydrothermally modified slow release corn starch: a potential new therapeutic option for treating hypoglycemia in autoimmune hypoglycemia (Hirata’s disease)

    Article • European Journal of Clinical Nutrition, September 2015, Springer Science + Business Media

    Dr. med. Katharina Lechner